Lowering Inflammation Level by Lp-PLA2 Inhibitor (Darapladib) in Early Atherosclerosis Development: in vivo Rat Type 2 Diabetes Mellitus Model
Conclusions: Darapladib proved
to have anti inflammation role on T2DM model.Keywords:Darapladib.,inflammation,Lipoprotein-associated phospholipase A2,oxidative stress,Type 2 diabetes mellitusView:PDF (2.7 MB)Click here to download the PDF file.‹ Homocysteine-Is there any role in Coronary Heart Disease?Changing Trends of Infective Endocarditis in India: A South Indian Experience ›
Source: Journal of Cardiovascular Disease Research - Category: Cardiology Authors: yunus Source Type: research
More News: Anatomy | Biochemistry | Cardiology | Cardiovascular | Coronary Heart Disease | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocarditis | Endocrinology | Heart | Heart Disease | India Health | Indonesia Health | Infective Endocarditis | Insulin | Internal Medicine | Laboratory Medicine | Nutrition | Pathology | Study | Veterinary Research
MedWorm Privacy Policy
Disclaimer
Copyright © MedWorm 2006-2024